Achilles Therapeutics plc
Achilles Therapeutics Holdings Limited
Achilles Therapeutics UK Limited
(“The Companies”)

Ian Harvey Dean and Robert Scott Fishman (“the Liquidators”) were appointed Joint Liquidators of the Companies further to resolutions of the respective member of the Companies dated 20 March 2025.

All licensed Insolvency Practitioners of Teneo Financial Advisory Limited (“Teneo”) are licensed in the UK to act as Insolvency Practitioners by the Institute of Chartered Accountants in England and Wales.

For the purpose of section 231 of the Insolvency Act 1986 (“the Act”), the Liquidators confirm that they are authorised to carry out all functions, duties and powers by either of them jointly and severally.

The Liquidations are Members’ Voluntary (Solvent) Liquidations pursuant to the Act. All distributions to creditors and shareholders have now been made and the Liquidators are in the process of completing the remaining formalities required to bring the Liquidations to a close.

Any queries in relation to the Liquidations should be directed to the Liquidators by email at Achilles@teneo.com or by post to C/O Teneo Financial Advisory Limited, The Colmore Building, 20 Colmore Circus Queensway, Birmingham, B4 6AT.

Please note that this website will be maintained until Q1 2027, thereafter access will be removed and it will be decommissioned.